Metavant

Vivek Ramaswamy’s Metavant hits a brick wall, abandoning a lead program for diabetes. And there’s nothing visible left to see here
Endpoints
Fri, 11/20/20 - 11:20 am
Metavant
diabetes
Vivek Ramaswamy
imeglimin